Corresponding Author: S. Andrew Josephson, MD, University of California, San Francisco, Neurology, 505 Parnassus Ave, Box 0114, San Francisco, California 94143 (firstname.lastname@example.org).
Published Online: April 10, 2020. doi:10.1001/jamaneurol.2020.1065
Correction: This article was corrected on June 8, 2020, to add an additional reference.
Conflict of Interest Disclosures: Dr Pleasure received grants from National Institute of Mental Health, the Weill Institute for Neuroscience, the Brain Research Foundation, and the George and Judy Marcus Fund for Innovation. Dr Green reported personal fees from Viela Bio, Mylan, Bionure, and Neurona; other support from Pipeline Therapeutics; and grants and other support from Inception Sciences outside the submitted work. Dr Josephson reported personal fees from JAMA Neurology and personal fees from Continuum Audio outside the submitted work. No other disclosures were reported.
CS . Olfactory neuropathy in severe acute respiratory syndrome: report of a case. Acta Neurol Taiwan
. 2006;15(1):26-28.PubMedGoogle Scholar
Y-C , Bai
W-Z , Hashikawa
T . The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients. J Med Virol
. 2020. doi:10.1002/jmv.25824
WJ , Ni
ZY , Hu
et al; China Medical Treatment Expert Group for Covid-19. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med
. 2020. doi:10.1056/NEJMoa2002032